BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 27664046)

  • 1. Hypoxia and inflammatory bowel disease.
    Cummins EP; Crean D
    Microbes Infect; 2017 Mar; 19(3):210-221. PubMed ID: 27664046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-sensitive pathways in intestinal inflammation.
    Brown E; Taylor CT
    J Physiol; 2018 Aug; 596(15):2985-2989. PubMed ID: 29114885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia Inducible Factor (HIF) Hydroxylases as Regulators of Intestinal Epithelial Barrier Function.
    Manresa MC; Taylor CT
    Cell Mol Gastroenterol Hepatol; 2017 May; 3(3):303-315. PubMed ID: 28462372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of IBD associated diarrhea.
    Anbazhagan AN; Priyamvada S; Alrefai WA; Dudeja PK
    Tissue Barriers; 2018; 6(2):e1463897. PubMed ID: 29737913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].
    Ochsenkühn T; Sackmann M; Göke B
    Radiologe; 2003 Jan; 43(1):1-8. PubMed ID: 12552369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease.
    Uhlig HH
    Gut; 2013 Dec; 62(12):1795-805. PubMed ID: 24203055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging Inflammatory Hypoxia in the Murine Gut.
    Whitney AK; Campbell EL
    Methods Mol Biol; 2016; 1422():115-26. PubMed ID: 27246027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolome and inflammasome in inflammatory bowel disease.
    Nanau RM; Neuman MG
    Transl Res; 2012 Jul; 160(1):1-28. PubMed ID: 22687960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of hypoxia-inducible factor 1-alpha in inflammatory bowel disease.
    Yin J; Ren Y; Yang K; Wang W; Wang T; Xiao W; Yang H
    Cell Biol Int; 2022 Jan; 46(1):46-51. PubMed ID: 34658125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects.
    Papa A; Scaldaferri F; Danese S; Guglielmo S; Roberto I; Bonizzi M; Mocci G; Felice C; Ricci C; Andrisani G; Fedeli G; Gasbarrini G; Gasbarrini A
    Dig Dis; 2008; 26(2):149-55. PubMed ID: 18431065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etiology and pathogenesis of inflammatory bowel disease.
    Schmidt C; Stallmach A
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):127-45. PubMed ID: 15990703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A tale of two diseases: the history of inflammatory bowel disease.
    Mulder DJ; Noble AJ; Justinich CJ; Duffin JM
    J Crohns Colitis; 2014 May; 8(5):341-8. PubMed ID: 24094598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Intestinal Microbiota in Inflammatory Bowel Disease.
    Becker C; Neurath MF; Wirtz S
    ILAR J; 2015; 56(2):192-204. PubMed ID: 26323629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of epithelial cells in the pathogenesis and treatment of inflammatory bowel disease.
    Okamoto R; Watanabe M
    J Gastroenterol; 2016 Jan; 51(1):11-21. PubMed ID: 26138071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiopathogenesis of inflammatory bowel diseases.
    Danese S; Fiocchi C
    World J Gastroenterol; 2006 Aug; 12(30):4807-12. PubMed ID: 16937461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of disrupted intestinal barrier in inflammatory bowel diseases.
    Salim SY; Söderholm JD
    Inflamm Bowel Dis; 2011 Jan; 17(1):362-81. PubMed ID: 20725949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inflammatory bowel disease: IBD].
    Endo K; Shiga H; Kinouchi Y; Shimosegawa T
    Rinsho Byori; 2009 Jun; 57(6):527-32. PubMed ID: 19621784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.